BK virus infections in pediatric kidney transplant recipients;PediatrikRenal Transplant Alicilarinda BK Virus Enfeksiyonlan

Mikrobiyoloji Bulteni

Volumn 47, Issue 3, 2013, Pages 461-471

  Mutlu, Derya ^a   Saǧlik, Imran ^a   Koyun, Mustafa ^a   Çomak, Elif ^a   Mutlu, Esvet ^a   Gokçeoclu, Arife Uslu ^a   Dogan, Serpil Çaǧla ^a   DlNÇKAN, Ayhan ^a   Akbaş, Sakine Halide ^a   Akkaya, Bahar ^a   Akman, Sema ^a   Süleymanlar, Gültekin ^a   Çolak, Dilek ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Bk virus; Nephropathy; Renal transplantation

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; CYTOSINE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; ISOXAZOLE DERIVATIVE; LEFLUNOMIDE; PHOSPHONIC ACID DERIVATIVE; VIRUS DNA;

ADOLESCENT; ARTICLE; BK VIRUS; CHILD; FEMALE; GENETICS; GRAFT REJECTION; HUMAN; ISOLATION AND PURIFICATION; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MALE; POLYOMAVIRUS INFECTION; TURKEY (REPUBLIC); VIRUS INFECTION;

ADOLESCENT; ANTIVIRAL AGENTS; BK VIRUS; CHILD; CYTOSINE; DNA, VIRAL; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; ORGANOPHOSPHONATES; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; TURKEY;

EID: 84884613940     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: 10.5578/mb.4957     Document Type: Article

References (27)

1. Sundaram SS, Landgraf jM, Neighbors K, et al. Adolescent health-related quality of life following liver and kidney transplantation. Am J Transplant 2007; 7(4): 982-9.
2. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342(9): 605-12. (Pubitemid 30118412)
3. Tantravahi J, Womer KL, Kaplan B. Why hasn't eliminating acute rejection improved graft survival? Annu Rev Med 2007; 58: 369-85. (Pubitemid 46706521)
4. Dharnidharka VR, Caillard S, Agodoa LY, Abbott KC. Infection frequency and profile in different age groups of kidney transplant recipients. Transplantation 2006; 81(12): 1662-7. (Pubitemid 43948299)
5. Hirsch HH. Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation. Amj Transplant 2002; 2(1): 25-30.
6. Wadei HM, Rule AD, Lewin M, et al. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am j Transplant 2006; 6(5 Pt 1): 1025-32.
7. Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol 1999; 10(5): 1080-9. (Pubitemid 29203096)
8. Vilchez RA, Kusne S. Molecular and clinical perspectives of polyomaviruses: emerging evidence of importance in non-kidney transplant populations. Liver Transpl 2006; 12(10): 1457-63. (Pubitemid 44594274)
9. Mäntyjärvi RA, Meurman OH, Vihma L, Berglund B. A human papovavirus (B.K.), biological properties and seroepidemiology. Ann Clin Res 1973; 5(5): 283-7.
10. Heritage J, Chesters PM, McCance DJ. The persistence of papovavirus BK DNA sequences in normal human renal tissue. J Med Viral 1981; 8(2): 143-50. (Pubitemid 12247609)
11. Cinevri F, De Santis R, Comoli P, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003; 75(8): 1266-70. (Pubitemid 36513032)
12. Cinevri F, Azzi A, Hirsch HH, et al. Prospective monitoring of Polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am j Transplant 2007; 7(12): 2727-35.
13. Alexander RT, Langlois V, Tellier R, Robinson L, Hebert D. The prevalence of BK viremia and urinary viral shedding in a pediatric renal transplant population: a single-center retrospective analysis. Pediatr Transplant 2006; 10(5): 586-92.
14. Vats A, Shapiro R, Singh Randhawa P, et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003; 75(1): 10512.
15. Ozen NS, Mutlu D, Ozcan A, Colak D. Evaluation of analytical performance of real time quantitative BKV PCR assay.) Clin Virol 2009; 46(Suppl 1): S60.
16. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005; 79(10): 1277-86. (Pubitemid 40734783)
17. Smith JM, McDonald RA, Finn LS, Healey PJ, Davis CL, Limaye AP. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant 2004; 4(12): 2109-17. (Pubitemid 39611641)
18. Fogeda M, Munoz P, Luque A, Morales MD, Bouza E; BKV Study Group. Cross-sectional study of BK virus infection in pediatric kidney transplant recipients. Pediatr Transplant 2007; 11 (4): 394-401. (Pubitemid 46669062)
19. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9(Suppl 3): S1-155.
20. Hoffman NG, Cook L, Atienza EE, Limaye AP, Jerome KR. Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays. J Clin Microbiol 2008; 46(8): 2671-80.
21. Drachenberg CB, Hirsch HH, Ramos E, Papadimitriou JC. Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methods. Hum Pathol 2005; 36(12): 1245-55. (Pubitemid 41682279)
22. Babel N, Fendt J, Karaivanov S, et al. Sustained BK viruria as an early marker for the development of BKVassociated nephropathy: analysis of 4128 urine and serum samples. Transplantation 2009; 88(1): 89-95.
23. Funk GA, Steiger J, Hirsch HH. Rapid dynamics of Polyomavirus type BK in renal transplant recipients. J Infect Dis 2006; 193(1): 80-7. (Pubitemid 43032502)
24. Rinaldo CH, Hirsch HH. Antivirals for the treatment of Polyomavirus BK replication. Expert Rev Anti Infect Ther 2007; 5(1): 105-15. (Pubitemid 46613388)
25. Ramos E, Drachenberg CB, Portocarrero M, et al. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. Clin Transpl 2002:143-53.
26. Binet l, Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 1999; 67(6): 918-22.
27. Laskin BL, Goebel J, Starke JR, Schauer DP, Eckman MH. Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children. Am j Kidney Dis 2013; 61(1): 22-32.